News
Aquestive Therapeutics (AQST) has priced an underwritten offering of 21.25M shares at $4.00 each, expecting $85M in gross proceeds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback